Trade Name: Gemzar ® Drug Type: Gemcitabine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Gemcitabine is classified as an antimetabolite.
Gemcitabine official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.
Gemzar(gemcitabine for injection, USP)is a nucleoside metabolic inhibitorthat exhibits antitumor activity. Gemcitabine HCl is 2´-deoxy-2´,2´-difluorocytidine ...
Gemcitabine (pronunciation: jem-SITE-a-been) is a nucleoside analog used as chemotherapy. It is marketed as Gemzar by Eli Lilly and Company. It is on the WHO Model ...
Gemcitabine is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Gemcitabine is used to treat cancers of the pancreas, lung ...
FDA Approval for Gemcitabine Hydrochloride. Use in Cancer. Gemcitabine hydrochloride is approved to be used alone or with other drugs to treat: Breast cancer that has ...
Read about the cancer treatment drug gemcitabine, otherwise known as Gemzar, including what it is, how it works and possible side effects.
Introduction Gemcitabine is a cytosine analogue and intravenously administered antineoplastic agent used in the therapy of several forms of advanced ...
Easy to read patient leaflet for gemcitabine. Includes indications, proper use, special instructions, precautions, and possible side effects.
Learn about gemcitabine for various cancer treatments. Possible gemcitabine side effects may include nausea, vomiting, diarrhea, hair loss, and/or other aftereffects.